Personal profile
Headline
ASSISTANT PROFESSOR | Medicine, Hematology and Medical Oncology
Biography
I am a medical oncologist who specializes in the care of patients with gastrointestinal malignancies. My research interests focus on the investigation of new therapies for these diseases, particularly cancers of the liver and biliary system.
Fingerprint
Dive into the research topics where Celina Ang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Phase II Trial of an Extended-Release siRNA Implant Targeting KRASG12D/V in Locally Advanced Pancreatic Cancer
Alagesan, B., Varghese, A. M., Ang, C., Gutierrez, M., Kamar, M., Passhak, M., Geva, R., Yarom, N., Lahav, M., Ligresti, R., Khamaysi, I., Bhutani, M. S., Phillips, A., Matalon, S., Pollack-Shragai, O., Rom, D., Shirvan, M., Javle, M. M., Park, W. & Yu, K. & 4 others, , 15 Mar 2026, In: Clinical Cancer Research. 32, 6, p. 1059-1067 9 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
The use of advanced machine learning to predict outcomes after atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: a retrospective cohort study
Vithayathil, M., Manfredi, G. F., D’Alessio, A., Fulgenzi, C. A. M., Celsa, C., Lombardi, P., Torkpour, A., Stefanini, B., Galle, P. R., Nishida, N., Scheiner, B., Crowley, F., Wu, L., Ang, C., Marron, T. U., Hsu, W. F., Lin, C. Y., Lin, R. P. T., Ulahannan, S. V. & Andanamala, H. & 39 others, , Feb 2026, In: The Lancet Digital Health. 8, 2, 100952.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Adjuvant Hepatic Arterial Infusion Chemotherapy for Resectable Colorectal Liver Metastases
Bokhoven, H., Fakih, M. G., Ang, C. & Koerkamp, B. G., 1 Jan 2025, Hepatic Arterial Infusion for Malignancy. Springer Science+Business Media, p. 177-190 14 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
-
ALBI Grade Enables Risk Stratification for Bleeding Events and Refines Prognostic Prediction in Advanced HCC Following Atezolizumab and Bevacizumab
Stefanini, B., Fulgenzi, C. A. M., Scheiner, B., Korolewicz, J., Cheon, J., Nishida, N., Ang, C., Marron, T. U., Wu, Y. L., Saeed, A., Wietharn, B., Rimassa, L., Pirozzi, A., Cammarota, A., Pressiani, T., Pinter, M., Balcar, L., Huang, Y. H., Mehan, A. & Phen, S. & 23 others, , 2025, In: Journal of Hepatocellular Carcinoma. 12, p. 671-683 13 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment
Celsa, C., Cabibbo, G., Fulgenzi, C. A. M., Battaglia, S., Enea, M., Scheiner, B., D'Alessio, A., Manfredi, G. F., Stefanini, B., Nishida, N., Galle, P. R., Schulze, K., Wege, H., Ciccia, R., Hsu, W. F., Vivaldi, C., Wietharn, B., Lin, R. P. T., Pirozzi, A. & Pressiani, T. & 35 others, , 1 Mar 2025, In: Hepatology. 81, 3, p. 837-852 16 p.Research output: Contribution to journal › Article › peer-review
Open Access57 Scopus citations
Press/Media
-
Researcher at University Medical Center Hamburg-Eppendorf Discusses Research in Antineoplastic Monoclonal Antibodies (Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational ...)
Wu, L. & Ang, C.
14/11/23
1 item of Media coverage
Press/Media
-
New Liver Cancer Study Findings Reported from Icahn School of Medicine at Mount Sinai (Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus ...)
Ang, C. & Wu, L.
23/12/22
1 item of Media coverage
Press/Media